Left ventricular wall thickness and disease duration in systemic sclerosis.

od Hegedüs, I., Czirják, L.
Wydane 1993

Exposure to chemicals and systemic sclerosis.

od Czirják, L, Csiki, Z, Nagy, Z, Tóth, E
Wydane 1995

Myocardial gallium-67 citrate scintigraphy in patients with systemic sclerosis.

od Gaál, J, Hegedüs, I, Dévényi, K, Czirják, L
Wydane 1995

Self limiting lupus-like symptoms in patients with parvovirus B19 infection

od Tovari, E, Mezey, I, Hedman, K, Czirjak, L
Wydane 2002

Changes in pulmonary function in systemic sclerosis.

od Czirják, L., Szolnoki, E., Nagy, Z., Szegedi, G.
Wydane 1992

Polymorphonuclear neutrophil function in systemic sclerosis.

od Czirják, L, Dankó, K, Sipka, S, Zeher, M, Szegedi, G
Wydane 1987

Relationship between natural and infection‐induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA

od Böröcz, K., Simon, D., Erdő‐Bonyár, S., Kovács, K. T., Tuba, É., Czirják, L., Németh, P., Berki, T.
Wydane w Clin Exp Immunol (2020)

European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria

od Valentini, G, Bencivelli, W, Bombardieri, S, D'Angelo, S, Della, R, Silman, A, Black, C, Czirjak, L, Nielsen, H, Vlachoyiannopoulo..., P
Wydane 2003

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

od Walker, U A, Tyndall, A, Czirják, L, Denton, C, Farge‐Bancel, D, Kowal‐Bielecka, O, Müller‐Ladner, U, Bocelli‐Tyndall, C, Matucci‐Cerinic, M
Wydane 2007

Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemi...

od Csuka, D., Simon, D., Hóbor, R., Uray, K., Prohászka, Z., Bánlaki, Z., Jani, P. K., Szilágyi, Á., Hudecz, F., Rajczy, K., Beke, G., Boros Major, A., Tordai, A., Illés, Z., Berki, T., Czirják, L., Füst, G.
Wydane 2013

Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patien...

od Allanore, Y, Borderie, D, Airo, P, Guiducci, S, Czirják, L, Nasonov, E L, Riemekasten, G, Caramaschi, P, Majdan, M, Krasowska, D, Friedl, E, Lemarechal, H, Ananieva, L P, Nievskaya, T, Ekindjian, O G, Matucci‐Cerinic, M, Kahan, A
Wydane 2007

Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey

od Blagojevic, J., Bellando-Randone, S., Abignano, G., Avouac, J., Cometi, L., Czirják, L., Denton, C. P., Distler, O., Frerix, M., Guiducci, S., Huscher, D., Jaeger, V. K., Lóránd, V., Maurer, B., Nihtyanova, S., Riemekasten, G., Siegert, E., Tarner, I. H., Vettori, S., Walker, U. A., Allanore, Y., Müller-Ladner, U., Del Galdo, F., Matucci-Cerinic, M.
Wydane w Arthritis Res Ther (2019)

European multicentre study to define disease activity criteria for systemic sclerosis.(*) II. Identification of disease activity variables and development of preliminary activity i...

od Valentini, G, Della, R, Bombardieri, S, Bencivelli, W, Silman, A, D'Angelo, S, Cerinic, M, Belch, J, Black, C, Bruhlmann, P, Czirjak, L, De Luca, A, Drosos, A, Ferri, C, Gabrielli, A, Giacomelli, R, Hayem, G, Inanc, M, McHugh, N, Nielsen, H, Rosada, M, Scorza, R, Stork, J, Sysa, A, van den Hoogen, F H J, Vlachoyiannopoulo..., P
Wydane 2001

European multicentre study to define disease activity criteria for systemic sclerosis.(*) I. Clinical and epidemiological features of 290 patients from 19 centres

od Della, R, Valentini, G, Bombardieri, S, Bencivelli, W, Silman, A, D'Angelo, S, Cerinic, M, Belch, J, Black, C, Becvar, R, Bruhlman, P, Cozzi, F, Czirjak, L, Drosos, A, Dziankowska, B, Ferri, C, Gabrielli, A, Giacomelli, R, Hayem, G, Inanc, M, McHugh, N, Nielsen, H, Scorza, R, Tirri, E, van den Hoogen, F H J, Vlachoyiannopoulo..., P
Wydane 2001